OBJECTIVE: Myelin disruption is an important feature of Alzheimer's disease (AD) that contributes to impairment of neuronal circuitry and cognition. In this study we characterize myelin degradation in the brains of patients with Alzheimer's disease compared with normal aged controls. METHODS: Myelin from patients with AD (n=13) was compared to matched controls (n=6). Myelin degradation was examined by immunohistochemistry in frontal white matter (WM) for intact myelin basic protein (MBP), degraded MBP, the presence of myelin lipid and for PAS staining. The relationship of myelin degradation and axonal injury was also assessed. RESULTS: Brains from patients with AD had significant loss of intact MBP, and an increase in degraded MBP in periventricular WM adjacent to a denuded ependymal layer. In regions of myelin degradation, vesicles were identified that stained positive for degraded MBP, myelin lipid, and neurofilament but not for intact MBP. Most vesicles stained for PAS, a corpora amylacea marker. The vesicles were significantly more abundant in the periventricular WM of AD patients compared to controls (44.5 ± 11.0 versus 1.7 ± 1.1, p=0.02). CONCLUSION: In AD patients degraded MBP is associated in part with vesicles particularly in periventricular WM that is adjacent to areas of ependymal injury.
OBJECTIVE: Myelin disruption is an important feature of Alzheimer's disease (AD) that contributes to impairment of neuronal circuitry and cognition. In this study we characterize myelin degradation in the brains of patients with Alzheimer's disease compared with normal aged controls. METHODS: Myelin from patients with AD (n=13) was compared to matched controls (n=6). Myelin degradation was examined by immunohistochemistry in frontal white matter (WM) for intact myelin basic protein (MBP), degraded MBP, the presence of myelin lipid and for PAS staining. The relationship of myelin degradation and axonal injury was also assessed. RESULTS: Brains from patients with AD had significant loss of intact MBP, and an increase in degraded MBP in periventricular WM adjacent to a denuded ependymal layer. In regions of myelin degradation, vesicles were identified that stained positive for degraded MBP, myelin lipid, and neurofilament but not for intact MBP. Most vesicles stained for PAS, a corpora amylacea marker. The vesicles were significantly more abundant in the periventricular WM of ADpatients compared to controls (44.5 ± 11.0 versus 1.7 ± 1.1, p=0.02). CONCLUSION: In ADpatients degraded MBP is associated in part with vesicles particularly in periventricular WM that is adjacent to areas of ependymal injury.
Authors: H Satoi; H Tomimoto; R Ohtani; T Kitano; T Kondo; M Watanabe; N Oka; I Akiguchi; S Furuya; Y Hirabayashi; T Okazaki Journal: Neuroscience Date: 2005 Impact factor: 3.590
Authors: D Y Lee; E Fletcher; O Martinez; M Ortega; N Zozulya; J Kim; J Tran; M Buonocore; O Carmichael; C DeCarli Journal: Neurology Date: 2009-10-21 Impact factor: 9.910
Authors: W J Strittmatter; A M Saunders; D Schmechel; M Pericak-Vance; J Enghild; G S Salvesen; A D Roses Journal: Proc Natl Acad Sci U S A Date: 1993-03-01 Impact factor: 11.205
Authors: Ilana J Bennett; Dana E Greenia; Pauline Maillard; S Ahmad Sajjadi; Charles DeCarli; Maria M Corrada; Claudia H Kawas Journal: Neurobiol Aging Date: 2017-04-26 Impact factor: 4.673
Authors: Lissette Gomez; Gabriel J Odom; Juan I Young; Eden R Martin; Lizhong Liu; Xi Chen; Anthony J Griswold; Zhen Gao; Lanyu Zhang; Lily Wang Journal: Nucleic Acids Res Date: 2019-09-26 Impact factor: 16.971
Authors: Xinhua Zhan; Glen C Jickling; Bradley P Ander; Boryana Stamova; DaZhi Liu; Patricia F Kao; Mariko A Zelin; Lee-Way Jin; Charles DeCarli; Frank R Sharp Journal: J Alzheimers Dis Date: 2015 Impact factor: 4.472